This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Lamotrigine and serious skin reactions

Authoring team

A skin rash occurs in 5-10% of patients treated with lamotrigine (typically within the first 6 weeks of treatment). Serious skin reactions occur in about 1 in 1000 patients, including Stevens Johnson syndrome and toxic epidermal necrolysis. The risk of serious skin reactions is much higher in children with a frequency of 1:300 to 1:100 (1).

Risk factors for the development of skin reactions include (2):

  • concomitant use of sodium valproate
  • exceeding the starting dose of lamotrigine
  • exceeding rate of dose excalation of lamotrigine

Reference:

  • Drugs and Therapeutics Bulletin (1992), 30 , 75-76.
  • Current problems in pharmacovigilance (1997), 23, 8.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.